bf/NASDAQ:ACER_icon.jpeg

NASDAQ:ACER

Acer Therapeutics Inc.

  • Stock

USD

Last Close

0.80

20/11 20:59

Market Cap

16.15M

Beta: 0.57

Volume Today

574.67K

Avg: 328.16K

PE Ratio

−0.27

PFCF: −0.41

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
336.52K
-
248.13K
26.26%
248.13K
0%
547.11K
-
547.11K
0%
average payables
699.32K
-
721.17K
3.12%
558.90K
22.50%
236.91K
57.61%
564.85K
138.42%
797.46K
41.18%
1.12M
40.02%
1.54M
37.82%
2.61M
69.57%
average receivables
-336.52K
-
1.26K
100.38%
1.26K
0%
2.50M
-
2.50M
0%
book value per share
19.60
-
17.01
13.21%
3.98
76.63%
6.05
52.07%
5.27
12.84%
1.82
65.46%
0.74
59.37%
-0.12
116.33%
-1.06
780.01%
capex per share
-0.50
-
-0.16
67.51%
-0.00
98.90%
-0.02
848.26%
-0.01
34.29%
-0.02
58.65%
-0.00
94.47%
-0.00
292.82%
-0.01
181.92%
capex to depreciation
-0.49
-
-0.26
46.61%
-0.01
98.05%
-15.72
306,525.89%
-3.45
78.08%
-3.07
10.91%
-0.15
94.99%
-0.77
403.28%
-2.59
234.55%
capex to operating cash flow
0.01
-
0.01
34.67%
0.00
98.49%
0.00
3,260.41%
0.01
29.30%
0.01
5.21%
0.00
89.44%
0.41
63,509.49%
0.01
98.61%
capex to revenue
-0.15
-
-0.04
75.93%
-0.00
98.84%
0.26
60,806.29%
-0.22
186.74%
-0.04
-
cash per share
26.10
-
22.26
14.70%
5.06
77.26%
4.23
16.33%
4.87
15.03%
1.20
75.43%
0.52
56.71%
0.89
71.95%
0.15
83.42%
days of inventory on hand
days payables outstanding
days sales outstanding
0.36
-
1.45K
-
debt to assets
0.01
-
0.04
293.72%
0.03
-
0.02
9.25%
0.01
56.43%
1.02
9,296.25%
debt to equity
0.02
-
0.06
275.20%
0.03
-
0.04
38.00%
-0.23
615.83%
-0.71
209.78%
dividend yield
earnings yield
-0.66
-
-0.74
11.51%
-1.22
66.07%
-0.28
77.33%
-0.12
55.43%
-0.71
477.21%
-0.79
10.12%
-0.45
42.39%
-0.70
55.49%
enterprise value
12.87M
-
3.87M
69.90%
3.23M
16.58%
35.52M
998.93%
130.46M
267.24%
28.98M
77.78%
23.74M
18.09%
20.21M
14.85%
49.11M
142.95%
enterprise value over ebitda
-0.88
-
-0.33
62.40%
-0.57
72.55%
-2.55
347.67%
-6.12
140.23%
-0.97
84.18%
-1.05
7.88%
-1.26
20.82%
-1.98
56.69%
ev to operating cash flow
-0.91
-
-0.37
59.35%
-0.35
4.71%
-2.52
617.51%
-7.86
212.06%
-0.98
87.51%
-1.39
41.95%
-149.84
10,647.22%
-1.62
98.92%
ev to sales
10.12
-
1.52
85.02%
1.11
26.59%
-144.22
13,061.97%
301.90
309.33%
16.04
-
free cash flow per share
-37.90
-
-18.76
50.50%
-13.52
27.91%
-3.83
71.66%
-1.95
49.11%
-2.94
50.84%
-1.53
47.91%
-0.01
99.13%
-1.93
14,401.16%
free cash flow yield
-0.63
-
-0.65
2.94%
-1.41
117.11%
-0.28
80.40%
-0.10
64.97%
-0.73
656.81%
-0.58
20.28%
-0.01
99.00%
-0.77
13,072.37%
graham net net
14.60
-
14.21
2.70%
3.36
76.38%
3.68
9.77%
4.22
14.51%
0.89
78.90%
-0.06
106.34%
-1.47
2,503.86%
-1.65
12.43%
graham number
132.22
-
90.20
31.78%
32.38
64.10%
22.86
29.40%
17.17
24.88%
10.83
36.96%
5.85
45.93%
1.68
71.38%
6.50
288.12%
income quality
0.94
-
0.87
7.26%
1.15
31.86%
0.99
13.89%
0.78
21.50%
1.00
28.68%
0.74
25.82%
0.01
98.82%
1.15
13,039.50%
intangibles to total assets
0
-
0
0
0.32
Infinity%
0.15
51.90%
0.36
136.02%
0.52
44.64%
0.21
59.69%
0.66
211.91%
interest coverage
-7.60K
-
-56.92
-
-22.00K
38,551.04%
-242.67
-
interest debt per share
0.01
-
0.26
4,923.32%
0.23
12.30%
0.07
71.18%
0.00
99.83%
0.06
50,544.45%
0.03
43.93%
0.03
15.74%
0.76
2,649.43%
inventory turnover
invested capital
0.02
-
0.06
275.20%
0.03
-
0.04
38.00%
-0.23
615.83%
-0.71
209.78%
market cap
22.78M
-
16.31M
28.39%
6.52M
60.02%
51.17M
684.68%
172.13M
236.40%
40.47M
76.49%
29.14M
28.00%
32.53M
11.65%
39.58M
21.65%
net current asset value
6.30M
-
8.78M
39.28%
2.66M
69.74%
14.49M
445.67%
37.17M
156.44%
9.79M
73.66%
51.67K
99.47%
-9.89M
19,242.60%
-24.87M
151.40%
net debt to ebitda
0.68
-
1.06
56.78%
0.58
45.30%
1.12
93.81%
1.96
74.24%
0.38
80.36%
0.24
38.12%
0.77
223.80%
-0.38
149.93%
net income per share
-39.65
-
-21.26
46.38%
-11.72
44.85%
-3.84
67.23%
-2.49
35.26%
-2.86
15.04%
-2.06
28.05%
-1.03
49.86%
-1.77
71.17%
operating cash flow per share
-37.39
-
-18.59
50.28%
-13.52
27.28%
-3.82
71.78%
-1.94
49.18%
-2.92
50.79%
-1.53
47.63%
-0.01
99.38%
-1.92
20,192.19%
payables turnover
receivables turnover
1.01K
-
0.25
-
research and ddevelopement to revenue
9.53
-
3.93
58.78%
2.24
43.05%
-35.42
1,683.86%
28.82
181.35%
5.17
-
return on tangible assets
-1.28
-
-0.83
34.63%
-2.06
147.56%
-0.85
58.58%
-0.50
41.97%
-2.11
324.95%
-3.29
55.91%
-0.51
84.34%
-7.01
1,260.77%
revenue per share
3.35
-
4.52
34.96%
4.27
5.61%
-0.07
101.56%
0.05
175.76%
0.09
-
roe
-2.02
-
-1.25
38.22%
-2.95
135.92%
-0.64
78.45%
-0.47
25.72%
-1.57
233.05%
-2.78
77.09%
8.55
406.93%
1.66
80.55%
roic
-2.02
-
-1.23
39.16%
-2.79
126.46%
-0.64
77.21%
-0.47
25.73%
-1.50
218.19%
-2.55
69.73%
16.32
740.63%
5.62
65.55%
sales general and administrative to revenue
3.01
-
1.67
44.73%
1.07
35.48%
-21.21
2,073.09%
21.43
201.06%
8.49
-
shareholders equity per share
19.60
-
17.01
13.21%
3.98
76.63%
6.05
52.07%
5.27
12.84%
1.82
65.46%
0.74
59.37%
-0.12
116.33%
-1.06
780.01%
stock based compensation to revenue
-1.70
-
3.05
279.71%
1.82
-
tangible asset value
7.44M
-
9.62M
29.25%
2.71M
71.86%
14.57M
438.42%
37.32M
156.13%
10.60M
71.58%
577.07K
94.56%
-9.37M
1,723.88%
-24.41M
160.47%
tangible book value per share
19.60
-
17.01
13.21%
3.98
76.63%
3.94
0.80%
4.36
10.61%
1.05
75.91%
0.05
95.06%
-0.66
1,365.69%
-1.55
135.71%
working capital
7.53M
-
8.78M
16.52%
2.66M
69.74%
14.49M
445.67%
37.17M
156.44%
10.12M
72.78%
295.48K
97.08%
-1.02M
445.65%
-15.44M
1,411.26%

All numbers in USD (except ratios and percentages)